Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Can a Simple Geriatric Assessment Predict the Outcome of TURP?
Eredics K, Meyer C, Gschliesser T, Lodeta B, Heissler O, Kunit T, Madersbacher S. Eredics K, et al. Among authors: gschliesser t. Urol Int. 2020;104(5-6):367-372. doi: 10.1159/000506717. Epub 2020 Apr 1. Urol Int. 2020. PMID: 32235127 Free article.
The Impact of Gender on Tumour Stage in In-House Complications and Choice of Urinary Diversion: Results of the Austrian Cystectomy Registry.
Gschliesser T, Eredics K, Berger I, Szelinger M, Klingler HC, Colombo T, Ponholzer A, Plas E, Grubmüller K, Dunzinger M, Jeschke K, Würnschimmel E, Krause FS, Shariat S, Leeb K, Pelzer A, Riedl C, Rauchenwald M, Hübner W, Brössner C, Madersbacher S; Cystectomy Registry of the Austrian Society of Urology. Gschliesser T, et al. Urol Int. 2017;99(4):429-435. doi: 10.1159/000477672. Epub 2017 Jun 23. Urol Int. 2017. PMID: 28641294
Bladder cancer in nonagenarians: a multicentre study of 123 patients.
Eredics K, Bretterbauer KM, Comploj E, Friedl A, Gschliesser T, Lenart S, Seklehner S, Wimpissinger F, Madersbacher S. Eredics K, et al. Among authors: gschliesser t. BJU Int. 2018 Dec;122(6):1010-1015. doi: 10.1111/bju.14419. Epub 2018 Jul 26. BJU Int. 2018. PMID: 29804311
Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study.
Dieckmann KP, Pokrivcak T, Geczi L, Niehaus D, Dralle-Filiz I, Matthies C, Dienes T, Zschäbitz S, Paffenholz P, Gschliesser T, Pichler R, Mego M, Bader P, Zengerling F, Heinzelbecker J, Krausewitz P, Krege S, Aurilio G, Aksoy C, Hentrich M, Seidel C, Törzsök P, Nestler T, Majewski M, Hiester A, Buchler T, Vallet S, Studentova H, Schönburg S, Niedersüß-Beke D, Ring J, Trenti E, Heidenreich A, Wülfing C, Isbarn H, Pichlmeier U, Pichler M. Dieckmann KP, et al. Among authors: gschliesser t. Ther Adv Med Oncol. 2022 Mar 31;14:17588359221086813. doi: 10.1177/17588359221086813. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35386956 Free PMC article.
Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
Strenger V, Gschliesser T, Grisold A, Zarfel G, Feierl G, Masoud L, Hoenigl M, Resch B, Müller W, Urlesberger B. Strenger V, et al. Among authors: gschliesser t. Int J Antimicrob Agents. 2011 Jan;37(1):67-9. doi: 10.1016/j.ijantimicag.2010.09.010. Epub 2010 Nov 11. Int J Antimicrob Agents. 2011. PMID: 21074372